Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L13a pseudogene 15 (RPL13AP15) is a non-coding segment of DNA that resembles the gene for ribosomal protein L13a but does not produce a functional protein product. It is annotated as a pseudogene and has several aliases; it is one of many processed pseudogenes dispersed throughout the human genome due to evolutionary duplication events. RPL13AP15 does not participate in protein synthesis or have known physiological or pathological functions, and is not considered a therapeutic target
None. No mechanisms of action for drugs targeting this pseudogene; it is not a drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L13a pseudogene 15 (RPL13AP15).